selected publications academic article Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease. PHARMACEUTICS. 1244-1257. 2021 congress communication Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice 2021